Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in Ukraine
This cross-sectional study explores the prevalence of alcohol use problems, depression/anxiety symptoms, and suicidal ideations among patients of the opioid agonist treatment (OAT) programs in Ukraine and their co-occurrence. AUDIT, Generalized Anxiety Disorder-7 (GAD-7), and Patient Heal...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia.edu Journals
2024-04-01
|
| Series: | Academia Mental Health & Well-Being |
| Online Access: | https://www.academia.edu/118314148/Prevalence_of_alcohol_use_depressive_and_anxiety_symptoms_among_patients_of_opioid_agonist_treatment_programmes_in_Ukraine |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850254572483772416 |
|---|---|
| author | Vitalii Klymchuk Viktoriia Gorbunova Iryna Ivanchuk |
| author_facet | Vitalii Klymchuk Viktoriia Gorbunova Iryna Ivanchuk |
| author_sort | Vitalii Klymchuk |
| collection | DOAJ |
| description |
This cross-sectional study explores the prevalence of alcohol use problems, depression/anxiety symptoms, and suicidal ideations among patients of the opioid agonist treatment (OAT) programs in Ukraine and their co-occurrence. AUDIT, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) were used to measure mental health conditions. In addition, the number of missed visits on site for substitute medication for the last month was counted, and blood alcohol levels were recorded (Drager Alcotest 6820, Draeger, Lübeck, Germany). Data were collected from October 2021 to January 2022 (before the full-scale Russian invasion) based on OAT centers in Kyiv, Sumy, and Lviv. The sample size was 999 patients. The overall rate of signs of alcohol-related problems (AUDIT), depression symptoms (PHQ-9), and anxiety symptoms (GAD-7) in the sample was 3.8 (SD 5.424), –7.42 (SD 5.336), and 5.058 (SD 4.264), respectively. For alcohol-related problems, 16.4% of the participants reported harmful drinking (one-month prevalence). Depression symptoms from moderate to severe were found in 26.73% of cases, and generalized anxiety symptoms from moderate to severe levels were found in 14.71% of patients (2-week prevalence). The 2-week suicide ideation prevalence was 24.9% (a quarter of all OAT patients). General co-occurrence of depression and anxiety symptoms was equal to 13.31% of all patients who participated in the study (32.13% of all patients having depression or anxiety symptoms). There was an increase in the general co-occurrence ratio with an increase in the severity of alcohol-related problems from 10.66% to 54.55%. |
| format | Article |
| id | doaj-art-a07e478090a6466fbc3fa249de52817d |
| institution | OA Journals |
| issn | 2997-9196 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Academia.edu Journals |
| record_format | Article |
| series | Academia Mental Health & Well-Being |
| spelling | doaj-art-a07e478090a6466fbc3fa249de52817d2025-08-20T01:57:05ZengAcademia.edu JournalsAcademia Mental Health & Well-Being2997-91962024-04-011110.20935/MHealthWellB6210Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in UkraineVitalii Klymchuk0Viktoriia Gorbunova1Iryna Ivanchuk2Centre for Childhood and Youth Research, Department of Social Sciences, Faculty of Humanities, Education and Social Sciences, University of Luxembourg, Esch-sur-Alzette, L-4365, Luxembourg.Department of Behavioral and Cognitive Science, Faculty of Humanities, Education and Social Sciences, University of Luxembourg, Esch-sur-Alzette, L-4365, Luxembourg.Viral Hepatitis and Opioid Dependency Department, Center of Public Health of the Ministry of Health of Ukraine, Kyiv, 04071, Ukraine. This cross-sectional study explores the prevalence of alcohol use problems, depression/anxiety symptoms, and suicidal ideations among patients of the opioid agonist treatment (OAT) programs in Ukraine and their co-occurrence. AUDIT, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) were used to measure mental health conditions. In addition, the number of missed visits on site for substitute medication for the last month was counted, and blood alcohol levels were recorded (Drager Alcotest 6820, Draeger, Lübeck, Germany). Data were collected from October 2021 to January 2022 (before the full-scale Russian invasion) based on OAT centers in Kyiv, Sumy, and Lviv. The sample size was 999 patients. The overall rate of signs of alcohol-related problems (AUDIT), depression symptoms (PHQ-9), and anxiety symptoms (GAD-7) in the sample was 3.8 (SD 5.424), –7.42 (SD 5.336), and 5.058 (SD 4.264), respectively. For alcohol-related problems, 16.4% of the participants reported harmful drinking (one-month prevalence). Depression symptoms from moderate to severe were found in 26.73% of cases, and generalized anxiety symptoms from moderate to severe levels were found in 14.71% of patients (2-week prevalence). The 2-week suicide ideation prevalence was 24.9% (a quarter of all OAT patients). General co-occurrence of depression and anxiety symptoms was equal to 13.31% of all patients who participated in the study (32.13% of all patients having depression or anxiety symptoms). There was an increase in the general co-occurrence ratio with an increase in the severity of alcohol-related problems from 10.66% to 54.55%.https://www.academia.edu/118314148/Prevalence_of_alcohol_use_depressive_and_anxiety_symptoms_among_patients_of_opioid_agonist_treatment_programmes_in_Ukraine |
| spellingShingle | Vitalii Klymchuk Viktoriia Gorbunova Iryna Ivanchuk Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in Ukraine Academia Mental Health & Well-Being |
| title | Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in Ukraine |
| title_full | Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in Ukraine |
| title_fullStr | Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in Ukraine |
| title_full_unstemmed | Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in Ukraine |
| title_short | Prevalence of alcohol use and depressive/anxiety symptoms among patients of opioid agonist treatment programs in Ukraine |
| title_sort | prevalence of alcohol use and depressive anxiety symptoms among patients of opioid agonist treatment programs in ukraine |
| url | https://www.academia.edu/118314148/Prevalence_of_alcohol_use_depressive_and_anxiety_symptoms_among_patients_of_opioid_agonist_treatment_programmes_in_Ukraine |
| work_keys_str_mv | AT vitaliiklymchuk prevalenceofalcoholuseanddepressiveanxietysymptomsamongpatientsofopioidagonisttreatmentprogramsinukraine AT viktoriiagorbunova prevalenceofalcoholuseanddepressiveanxietysymptomsamongpatientsofopioidagonisttreatmentprogramsinukraine AT irynaivanchuk prevalenceofalcoholuseanddepressiveanxietysymptomsamongpatientsofopioidagonisttreatmentprogramsinukraine |